Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the Framingham heart study
JB Echouffo-Tcheugui, MI Short… - The Journal of …, 2019 - academic.oup.com
Context The natural histories of obesity subphenotypes are incompletely delineated.
Objectives To investigate dynamic changes in obesity subphenotypes and associations with …
Objectives To investigate dynamic changes in obesity subphenotypes and associations with …
Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences
A Tsatsoulis, SA Paschou - Current obesity reports, 2020 - Springer
Abstract Purpose of Review To present a comprehensive overview regarding criteria,
epidemiology, and controversies that have arisen in the literature about the existence and …
epidemiology, and controversies that have arisen in the literature about the existence and …
Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype
MH Seo, EJ Rhee - Endocrinology and metabolism, 2014 - synapse.koreamed.org
Metabolically healthy obesity (MHO) is a new concept in which an individual may exhibit an
obese phenotype in the absence of any metabolic abnormalities. There are a number of …
obese phenotype in the absence of any metabolic abnormalities. There are a number of …
Obesity and cardiovascular disease
The prevalence of obesity has increased worldwide over the past few decades. In 2013, the
prevalence of obesity exceeded the 50% of the adult population in some countries from …
prevalence of obesity exceeded the 50% of the adult population in some countries from …
Metabolic and body composition factors in subgroups of obesity: what do we know?
AD Karelis, DH St-Pierre, F Conus… - The Journal of …, 2004 - academic.oup.com
Obesity is thought to be a heterogeneous disorder with several possible etiologies;
therefore, by examining subtypes of obesity we attempt to understand obesity's …
therefore, by examining subtypes of obesity we attempt to understand obesity's …
Metabolically healthy obesity: definitions, protective factors, clinical relevance
TI Romantsova, EV Ostrovskaya - Almanac of clinical medicine, 2015 - almclinmed.ru
Obesity is a risk factor for the development of cardiovascular disease and type 2 diabetes;
nevertheless, in many obese patients no cardiometabolic complications are present. For this …
nevertheless, in many obese patients no cardiometabolic complications are present. For this …
Characterizing the profile of obese patients who are metabolically healthy
V Primeau, L Coderre, AD Karelis, M Brochu… - International journal of …, 2011 - nature.com
The presence of obesity-related metabolic disturbances varies widely among obese
individuals. Accordingly, a unique subset of obese individuals has been described in the …
individuals. Accordingly, a unique subset of obese individuals has been described in the …
Predicting the development of the metabolically healthy obese phenotype
I Achilike, HP Hazuda, SP Fowler, K Aung… - International journal of …, 2015 - nature.com
Objective: The metabolically healthy (MHO) and unhealthy obese (MUHO) differ in terms of
cardiovascular risk. However, little is known about predicting the development of these …
cardiovascular risk. However, little is known about predicting the development of these …
Metabolically healthy obesity: definitions, determinants and clinical implications
CM Phillips - Reviews in Endocrine and Metabolic Disorders, 2013 - Springer
Obesity is associated with increased risk of developing metabolic syndrome (MetS), type 2
diabetes mellitus (T2DM) and cardiovascular disease (CVD) leading to higher all-cause …
diabetes mellitus (T2DM) and cardiovascular disease (CVD) leading to higher all-cause …
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study
SL Appleton, CJ Seaborn, R Visvanathan… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE To determine the correlates of the “metabolically healthy obese”(MHO)
phenotype and the longitudinal risks of diabetes and cardiovascular disease (CVD)/stroke …
phenotype and the longitudinal risks of diabetes and cardiovascular disease (CVD)/stroke …